Immunotherapy of gynaecological high-risk human papilloma virus infection with human leukocyte ultrafiltrate

Infectious Diseases in Obstetrics and Gynecology

Volumn 8, Issue 3-4, 2000, Pages 120-123

  Spitzbart, H ^a   Hoyme, U B ^a  

^a Frauenklinik ^*  (Germany)

Author keywords

Antiviral therapy; Cervical HPV infection; Immunomodulating therapy

Indexed keywords

ADOPTIVE IMMUNOTHERAPY; ARTICLE; FEMALE; GYNECOLOGIC INFECTION; HUMAN; HUMAN TISSUE; IMMUNOMODULATION; LEUKOCYTE TRANSFUSION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; ULTRAFILTRATION; UTERINE CERVICITIS; UTERINE CERVIX CARCINOMA IN SITU; WART VIRUS;

EID: 0033864567     PISSN: 10647449     EISSN: None     Source Type: Journal    
DOI: 10.1002/1098-0997(2000)8:3/4<120::aid-idog5>3.0.co;2-n     Document Type: Article

References (12)

1. Sherman ME, Schiffman MH, Lorincz, AT, et al. Toward objective quality assurance in cervical cytopathology. Am J Clin Pathol 1994;102:182-187.
2. Kataja V, Syrjänen S, Mäntyjärvi R, et al. Prognostic factors in cervical human papillomavirus infections. Sex Trans Dis 1992;19:154-160.
3. Lorincz A, Reid R, Jenson AB, et al. Human papilloma-virus infection of the cervix: relative risk associations of 15 common anogenital types. Obstet Gynecol 1992;79: 328-337.
4. Cuzik J, Terry G, Ho L, Hollingworth T, Anderson M. Human papilloma-virus type 16 DANN in cervical smears as predictor of high-grade cervical cancer. Lancet 1992;339:959-960.
5. De Villiers EM, Wagner D, Schneider A, et al. Human papillomavirus DNA in women without and with cytological abnormalities: results of a 5-year follow-up study. Gynecol Oncol 1992;44:33-39.
6. Nuovo GJ, Maritz J, Walsh LL, Mac Connell P, Koulos J. Predictive value of human papillomavirus DNA detection by filter hybridization and polymerase chain reaction in women with negative results of colposcopic examination. Am J Clin Pathol 1992;98:489-492.
7. Yliskoski M, Tervahauta A, Saarikowski S, Mäutyjärvi R, Syrjänen K. Clinical course of cervical human papillomavirus lesions in relation to coexistent cervical infections. Sex Transm Dis 1992;19:137-139.
8. Von Krogh G, Hellberg D. Self-treatment using a 0.5% podophyllotoxin cream of external genital condylomata acuminata in women. Sex Transm Dis 1992;19:170-174.
9. Stellato G. Intralesional recombinant alpha 2b interferon in the treatment of human papillomavirus-associated cervical intraepithelial neoplasia. Sex Transm Dis 1992;19:124-126.
10. Edwards L, Ferency A, Baker D, et al. Self-administered topical 5% imiquimod cream for external genital warts. Arch Dermatol 1998;134:25-30.
11. Lungu O, Sun XW, Felix J, Richart RM, Silverstein S, Wright TC. Relationship of human papillomavirus type to grade of cervical intra-epithelial neoplasia. JAMA 1992;267:2493-2496.
12. Evans CH, Flugelman AA, Dipaolo JA. Cytokine modulation of immune defenses in cervical cancer. Oncology 1993;50:245-251.